L Bradbury

1.0k total citations
28 papers, 542 citations indexed

About

L Bradbury is a scholar working on Rheumatology, Hepatology and Molecular Biology. According to data from OpenAlex, L Bradbury has authored 28 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 6 papers in Hepatology and 5 papers in Molecular Biology. Recurrent topics in L Bradbury's work include Spondyloarthritis Studies and Treatments (19 papers), Rheumatoid Arthritis Research and Therapies (11 papers) and Liver Diseases and Immunity (6 papers). L Bradbury is often cited by papers focused on Spondyloarthritis Studies and Treatments (19 papers), Rheumatoid Arthritis Research and Therapies (11 papers) and Liver Diseases and Immunity (6 papers). L Bradbury collaborates with scholars based in United Kingdom, Australia and United States. L Bradbury's co-authors include Matthew A. Brown, Sinéad Brophy, Andrew E. Timms, B P Wordsworth, Andrei Călin, B. P. Wordsworth, Laurence A. Rubin, Katherine A. Siminovitch, Steve Edwards and Daniel E. Weeks and has published in prestigious journals such as The American Journal of Human Genetics, Annals of the Rheumatic Diseases and PLoS Genetics.

In The Last Decade

L Bradbury

26 papers receiving 528 citations

Peers

L Bradbury
Ivo Jajić Croatia
L Bradbury
Citations per year, relative to L Bradbury L Bradbury (= 1×) peers Ivo Jajić

Countries citing papers authored by L Bradbury

Since Specialization
Citations

This map shows the geographic impact of L Bradbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Bradbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Bradbury more than expected).

Fields of papers citing papers by L Bradbury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Bradbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Bradbury. The network helps show where L Bradbury may publish in the future.

Co-authorship network of co-authors of L Bradbury

This figure shows the co-authorship network connecting the top 25 collaborators of L Bradbury. A scholar is included among the top collaborators of L Bradbury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Bradbury. L Bradbury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ellis, Jonathan, David J. Pennisi, Xiaoxia Song, et al.. (2017). Transcriptome analysis of ankylosing spondylitis patients before and after TNF-α inhibitor therapy reveals the pathways affected. Genes and Immunity. 18(3). 184–190. 21 indexed citations
2.
Fischer, Román, David C. Trudgian, Cynthia Wright, et al.. (2012). Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis. QUT ePrints (Queensland University of Technology). 2 indexed citations
3.
McFarlane, J, L Bradbury, & Matthew Brown. (2011). Infliximab Therapy of Ankylosing Spondylitis Is Highly Effective But Associated with Weight Gain. Internal Medicine Journal. 41. 7–7. 2 indexed citations
4.
Bradbury, L, F. Geoghegan, R.A. Hannon, et al.. (2011). Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists. Osteoporosis International. 23(1). 285–294. 33 indexed citations
5.
Harvey, David, L Bradbury, Kari Laiho, et al.. (2008). Toll-like receptor 4 and CD14 polymorphisms in ankylosing spondylitis: evidence of a weak association in Finns.. PubMed. 35(8). 1609–12. 6 indexed citations
6.
Reveille, John D., L Bradbury, John C. Davis, et al.. (2007). Il-23r is a major determinant of ankylosing spondylitis risk - The tasc study. Annals of the Rheumatic Diseases. 66. 112–112. 7 indexed citations
7.
Pointon, J J, Andrew E. Timms, L Bradbury, Matthew A. Brown, & P Wordsworth. (2006). Analysis of positional candidate genes in ankylosing spondylitis: A possible role for ENPP1. Lara D. Veeken. 45. 1 indexed citations
8.
Barnardo, Martin, L Bradbury, Andrei Călin, et al.. (2006). Non-B27 MHC associations of ankylosing spondylitis. Genes and Immunity. 8(2). 115–123. 38 indexed citations
9.
Timms, Andrew E., et al.. (2005). Fine-mapping of the IL-1 gene cluster pinpoints genetic associations with ankylosing spondylitis.. Queensland's institutional digital repository (The University of Queensland). 52(9). 2 indexed citations
10.
Timms, Andrew E., et al.. (2003). Genetic testing for haemochromatosis in patients with chondrocalcinosis (vol 61, pg 745, 2002). Annals of the Rheumatic Diseases. 62. 192–192. 1 indexed citations
11.
Timms, Andrew E., et al.. (2003). Investigation of the role of ANKH in ankylosing spondylitis. Queensland's institutional digital repository (The University of Queensland). 3 indexed citations
12.
Jaakkola, E., L Bradbury, A Călin, et al.. (2003). TRANSFORMING GROWTH FACTOR BETA-1 GENE POLYMORPHISMS AND ANKYLOSING SPONDYLITIS. Lara D. Veeken. 42. 81–82. 1 indexed citations
13.
Timms, Andrew E., et al.. (2003). Investigation of the role of ANKHin ankylosing spondylitis. Arthritis & Rheumatism. 1 indexed citations
14.
Timms, Andrew E., et al.. (2003). Investigation of the role of ANKH in ankylosing spondylitis. Arthritis & Rheumatism. 48(10). 2898–2902. 48 indexed citations
15.
Crane, Alison M., L Bradbury, David A. van Heel, et al.. (2002). Role of NOD2 variants in spondylarthritis. Queensland's institutional digital repository (The University of Queensland). 7 indexed citations
16.
Bradbury, L, et al.. (2001). Is disease severity in ankylosing spondylitis genetically determined. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
17.
Brophy, Sinéad, L Bradbury, Andrew E. Timms, et al.. (2001). Towards defining the genetic determinants of disease severity in ankylosing spondylitis.. Queensland's institutional digital repository (The University of Queensland). 44(9). 5 indexed citations
18.
Edwards, Steven W., Andrew E. Timms, L Bradbury, B P Wordsworth, & Matthew A. Brown. (2001). Interleukin-1 and susceptibility to ankylosing spondylitis. Lara D. Veeken. 40. 17–17. 2 indexed citations
19.
Laval, Steven H., Andrew E. Timms, Steve Edwards, et al.. (2001). Whole-Genome Screening in Ankylosing Spondylitis: Evidence of Non-MHC Genetic-Susceptibility Loci. The American Journal of Human Genetics. 68(4). 918–926. 179 indexed citations
20.
Brown, Matthew A., S.H. Laval, Andrew E. Timms, et al.. (2000). Confirmation of non-MHC genetic loci by whole genome linkage studies in ankylosing spondylitis.. Queensland's institutional digital repository (The University of Queensland). 43(9). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026